<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35277106</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Silk fibroin hydrogel containing <i>Sesbania sesban</i> L. extract for rheumatoid arthritis treatment.</ArticleTitle>
        <Pagination>
          <StartPage>882</StartPage>
          <EndPage>888</EndPage>
          <MedlinePgn>882-888</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2050848</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Rheumatoid arthritis, a chronic and progressive inflammation condition in the joints, has significantly reduced the patient quality of life and life expectancy. Crucially, there is no complete therapy for this disease, and the current treatments possess numerous side effects. Thus, novel therapeutic approach is necessary. To that end, this study developed novel silk fibroin in-situ hydrogel containing <i>Sesbania sesban</i> L. extract, a plant with high anti-inflammatory actions that are beneficial for rheumatoid arthritis treatments.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The hydrogels were manufactured using simple method of spontaneous gelation at different temperature. The gel properties of morphology, gelation time, viscosity, gel strength, stability, drug loading capacity, drug release rate, and in-vitro anti-inflammatory activity were investigated with appropriate methods.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The optimal formulation had highly porous structure, with a gelation time of 0.5 h at room temperature and bodily temperature of 37 °C, a viscosity of 2530 ± 50 cP, a gel strength of 1880.14 ± 35.10 g, and a physical stability of &gt;6 months. Moreover, the hydrogel contained the <i>Sesbania sesban</i> L. leaf extract with a total phenolic content of 92.8 ± 8.30 mg GAE/g, and sustained the release rate for &gt;20 dạys, followed the Higuchi model. Regarding the in-vitro activities, all formulations were nontoxic to the RAW 264.7 cell line and demonstrated comparable anti-inflammatory activity to the free extract, in terms of the NO reduction levels.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Conclusively, the systems possessed potential properties to be further investigated to become a prospective rheumatoid arthritis treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pham</LastName>
            <ForeName>Duy Toan</ForeName>
            <Initials>DT</Initials>
            <Identifier Source="ORCID">0000-0002-8693-3367</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, College of Natural Sciences, Can Tho University, Can Tho, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thao</LastName>
            <ForeName>Nguyen Thi Phuong</ForeName>
            <Initials>NTP</Initials>
            <AffiliationInfo>
              <Affiliation>Dong Nai Technology University, Bien Hoa, Dong Nai, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thuy</LastName>
            <ForeName>Bui Thi Phuong</ForeName>
            <Initials>BTP</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Basic Sciences, Van Lang University, Ho Chi Minh City, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tran</LastName>
            <ForeName>Van De</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nguyen</LastName>
            <ForeName>Thanh Q C</ForeName>
            <Initials>TQC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, College of Natural Sciences, Can Tho University, Can Tho, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nguyen</LastName>
            <ForeName>Ngoc Nha Thao</ForeName>
            <Initials>NNT</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D020100">Hydrogels</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9007-76-5</RegistryNumber>
          <NameOfSubstance UI="D005349">Fibroins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005349" MajorTopicYN="Y">Fibroins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020100" MajorTopicYN="Y">Hydrogels</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049931" MajorTopicYN="Y">Sesbania</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hydrogel</Keyword>
        <Keyword MajorTopicYN="N">Sesbania sesban</Keyword>
        <Keyword MajorTopicYN="N">Silk fibroin</Keyword>
        <Keyword MajorTopicYN="N">anti-inflammation</Keyword>
        <Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>21</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35277106</ArticleId>
        <ArticleId IdType="pmc">PMC8920400</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2050848</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Almutairi K, Nossent J, Preen D, et al.  (2021). The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int
41:863–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33175207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behl, T., Mehta, K., Sehgal, A., Singh, S., Sharma, N., Ahmadi, A., Arora, S. and Bungau, S. (2021) Exploring the role of polyphenols in rheumatoid arthritis. Taylor &amp; Francis.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33998910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chomchalao P, Nimtrakul P, Pham DT, Tiyaboonchai W. (2020). Development of amphotericin B-loaded fibroin nanoparticles: a novel approach for topical ocular application. J Mater Sci
55:5268–79.</Citation>
        </Reference>
        <Reference>
          <Citation>Christman LM, Gu L. (2020). Efficacy and mechanisms of dietary polyphenols in mitigating rheumatoid arthritis. J Funct Foods
71:104003.</Citation>
        </Reference>
        <Reference>
          <Citation>Fitriansyah SN, Fidrianny I, Ruslan K. (2017). Correlation of total phenolic, flavonoid and carotenoid content of Sesbania sesban (L. Merr) leaves extract with DPPH scavenging activities. Int J Pharmacogn Phytochem Res 9:89–94.</Citation>
        </Reference>
        <Reference>
          <Citation>Grennan DM, Gray J, Loudon J, Fear S. (2001). Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis
60:214–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1753573</ArticleId>
            <ArticleId IdType="pubmed">11171680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Q, Wang Y, Xu D, et al.  (2018). Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res
6:1–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5920070</ArticleId>
            <ArticleId IdType="pubmed">29736302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim KS, Park SJ, Yang JA, et al.  (2011). Injectable hyaluronic acid–tyramine hydrogels for the treatment of rheumatoid arthritis. Acta Biomater
7:666–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20883838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J, Ko JH, Mansfield KM, et al.  (2018). Glucose-responsive trehalose hydrogel for insulin stabilization and delivery. Macromol Biosci
18:e1700372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5986559</ArticleId>
            <ArticleId IdType="pubmed">29665232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Mooney DJ. (2016). Designing hydrogels for controlled drug delivery. Nat Rev Mater
1:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5898614</ArticleId>
            <ArticleId IdType="pubmed">29657852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munde-Wagh KB, Wagh VD, Toshniwal SS, et al. (2012). Phytochemical, antimicrobial evaluation and determination of total phenolic and flavonoid contents of Sesbania grandiflora flower extract. Int J Pharm Pharm Sci 4:229–32.</Citation>
        </Reference>
        <Reference>
          <Citation>Oliveira IM, Fernandes DC, Cengiz IF, et al.  (2021). Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models. J Mater Sci Mater Med
32:74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8219548</ArticleId>
            <ArticleId IdType="pubmed">34156535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira IM, Gonçalves C, Shin ME, et al.  (2020). Anti-inflammatory properties of injectable betamethasone-loaded tyramine-modified gellan gum/silk fibroin hydrogels. Biomolecules
10:1456–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7603075</ArticleId>
            <ArticleId IdType="pubmed">33080875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira IM, Gonçalves C, Shin ME, et al.  (2020). Enzymatically crosslinked tyramine-gellan gum hydrogels as drug delivery system for rheumatoid arthritis treatment. Drug Deliv Transl Res
11: 1288–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32924098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandhare RB, Sangameswaran B, Mohite PB, Khanage SG. (2011). Antidiabetic activity of aqueous leaves extract of Sesbania sesban (L) Merr. in streptozotocin induced diabetic rats. Avicenna J Med Biotechnol
3:37–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3558175</ArticleId>
            <ArticleId IdType="pubmed">23407749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham DT, Phewchan P, Navesit K, et al.  (2021). Development of metronidazole-loaded in situ thermosensitive hydrogel for periodontitis treatment. Turkish J Pharm Sci
18:510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8430413</ArticleId>
            <ArticleId IdType="pubmed">34496558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham DT, Saelim N, Cornu R, et al.  (2020). Crosslinked fibroin nanoparticles: investigations on biostability, cytotoxicity, and cellular internalization. Pharmaceuticals
13:86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7281390</ArticleId>
            <ArticleId IdType="pubmed">32366020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham DT, Saelim N, Tiyaboonchai W. (2018). Crosslinked fibroin nanoparticles using EDC or PEI for drug delivery: physicochemical properties, crystallinity and structure. J Mater Sci
53:14087–103.</Citation>
        </Reference>
        <Reference>
          <Citation>Pham DT, Saelim N, Tiyaboonchai W. (2018). Design of experiments model for the optimization of silk fibroin based nanoparticles. Int J App Pharm
10:195–201.</Citation>
        </Reference>
        <Reference>
          <Citation>Pham DT, Saelim N, Tiyaboonchai W. (2019). Alpha mangostin loaded crosslinked silk fibroin-based nanoparticles for cancer chemotherapy. Colloids Surf B Biointerfaces
181:705–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31228853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham DT, Saelim N, Tiyaboonchai W. (2019). Paclitaxel loaded EDC-crosslinked fibroin nanoparticles: a potential approach for colon cancer treatment. Drug Deliv Transl Res 10:413–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31701488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham DT, Tetyczka C, Hartl S, et al.  (2020). Comprehensive investigations of fibroin and poly(ethylenimine) functionalized fibroin nanoparticles for ulcerative colitis treatment. J Drug Deliv Sci Technol
57:101484.</Citation>
        </Reference>
        <Reference>
          <Citation>Pham DT, Tiyaboonchai W. (2020). Fibroin nanoparticles: a promising drug delivery system. Drug Deliv
27:431–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7144220</ArticleId>
            <ArticleId IdType="pubmed">32157919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirmardvand Chegini S, Varshosaz J, Taymouri S. (2018). Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment. Artif Cells Nanomed Biotechnol
46:502–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29661045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sajid S, PawarVijay T. (2012). Anti-inflammatory activity of Sesbania sesban (L) Merr. Int Res J Pharm 3:176–80.</Citation>
        </Reference>
        <Reference>
          <Citation>Shyamala gowri S, Vasantha K. (2010). Antioxidant activity of Sesbania grandiflora (pink variety) L. Pers. Int J Eng Sci Technol 2:4350–6.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh B, Sharma R, Sharma R, et al.  (2017). Anti-inflammatory potential of root and stem extracts of Sesbania sesban. Ann Plant Sci
6:1790.</Citation>
        </Reference>
        <Reference>
          <Citation>Singleton VL, Orthofer R, Lamuela-Raventós RM. (1999). Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods Enzymol
299:152–178.</Citation>
        </Reference>
        <Reference>
          <Citation>Tatiya AU, Dande PR, Mutha RE, Surana SJ. (2013). Effect of saponins from of Sesbania sesban L.(Merr) on acute and chronic inflammation in experimental induced animals. J Biol Sci
13:123–30.</Citation>
        </Reference>
        <Reference>
          <Citation>Vigata M, Meinert C, Hutmacher DW, Bock N. (2020). Hydrogels as drug delivery systems: a review of current characterization and evaluation techniques. Pharmaceutics
12:1188–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7762425</ArticleId>
            <ArticleId IdType="pubmed">33297493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walekhwa MN, Ogeto TK, Murithi MK, Malago ZL. (2020). Pharmacological effects of Sesbania sesban: a systematic review. Int J Res Med Sci
8:1185.</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng H, Zuo B. (2021). Functional silk fibroin hydrogels: preparation, properties and applications. J Mater Chem B
9:1238–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33406183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziadlou R, Rotman S, Teuschl A, et al.  (2021). Optimization of hyaluronic acid-tyramine/silk-fibroin composite hydrogels for cartilage tissue engineering and delivery of anti-inflammatory and anabolic drugs. Mater Sci Eng C Mater Biol Appl
120:111701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33545860</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
